Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Advanced Metabolic & Body-Composition Research Stack
OZZ BODYSHIFT brings together four research compounds selected for investigation across multiple metabolic and body-composition pathways.
This advanced combination is positioned for researchers exploring metabolic signalling, cellular energy regulation, appetite-related pathways and growth-hormone-associated body-composition research.
Retatrutide 10mg
Investigated in research involving GLP-1, GIP and glucagon receptor pathways and their roles in metabolic signalling.
Tesamorelin 10mg
Studied in relation to growth-hormone signalling pathways and body-composition research.
MOTS-C 10mg
A mitochondrial-derived peptide investigated for its potential role in cellular energy regulation and metabolic function.
Cagrilintide 10mg
An amylin analogue studied in research involving appetite signalling, satiety pathways and metabolic regulation.
OZZ BODYSHIFT combines four distinct areas of research into one premium OZZ stack:
Metabolic Signalling
Explore multiple metabolic pathways within one research combination.
Energy Regulation
MOTS-C provides an additional area of investigation focused on mitochondrial and cellular energy processes.
Body-Composition Research
Tesamorelin provides a complementary pathway for research involving growth-hormone signalling and body composition.
Appetite & Satiety Pathways
Retatrutide and Cagrilintide provide separate research pathways involving metabolic and appetite-related signalling.
Four research compounds. Multiple pathways. One advanced research stack.
BODYSHIFT has been created for researchers wanting to investigate a broader range of metabolic and body-composition mechanisms within one convenient OZZ Peptides combination.
1 × Retatrutide 10mg
1 × Tesamorelin 10mg
1 × MOTS-C 10mg
1 × Cagrilintide 10mg
OZZ Peptides — Research Today. A Stronger Tomorrow.
For laboratory and research applications only. Not intended for human consumption.
Advanced Metabolic & Body-Composition Research Stack
OZZ BODYSHIFT brings together four research compounds selected for investigation across multiple metabolic and body-composition pathways.
This advanced combination is positioned for researchers exploring metabolic signalling, cellular energy regulation, appetite-related pathways and growth-hormone-associated body-composition research.
Retatrutide 10mg
Investigated in research involving GLP-1, GIP and glucagon receptor pathways and their roles in metabolic signalling.
Tesamorelin 10mg
Studied in relation to growth-hormone signalling pathways and body-composition research.
MOTS-C 10mg
A mitochondrial-derived peptide investigated for its potential role in cellular energy regulation and metabolic function.
Cagrilintide 10mg
An amylin analogue studied in research involving appetite signalling, satiety pathways and metabolic regulation.
OZZ BODYSHIFT combines four distinct areas of research into one premium OZZ stack:
Metabolic Signalling
Explore multiple metabolic pathways within one research combination.
Energy Regulation
MOTS-C provides an additional area of investigation focused on mitochondrial and cellular energy processes.
Body-Composition Research
Tesamorelin provides a complementary pathway for research involving growth-hormone signalling and body composition.
Appetite & Satiety Pathways
Retatrutide and Cagrilintide provide separate research pathways involving metabolic and appetite-related signalling.
Four research compounds. Multiple pathways. One advanced research stack.
BODYSHIFT has been created for researchers wanting to investigate a broader range of metabolic and body-composition mechanisms within one convenient OZZ Peptides combination.
1 × Retatrutide 10mg
1 × Tesamorelin 10mg
1 × MOTS-C 10mg
1 × Cagrilintide 10mg
OZZ Peptides — Research Today. A Stronger Tomorrow.
For laboratory and research applications only. Not intended for human consumption.